Circadian rhythms, symptoms, physical functioning, and body mass index in breast cancer survivors

Ann Malone Berger, Melody A Hertzog, Carol R. Geary, Patricia Fischer, Lynne Farr

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Introduction: Research has been limited in circadian activity rhythms and their relationship with health status in early-stage breast cancer survivors. Maintaining strong circadian parameters may reduce symptoms and improve physical functioning and disease-free survival. Methods: This is a descriptive, correlational, secondary analysis of data from a randomized controlled trial collected 1 year after the first chemotherapy treatment; n = 156 cases with 7 days of wrist actigraph data of six circadian activity rhythm parameters; measures of function, fatigue, sleep, and anxiety/depression; and demographic/medical data including body mass index (BMI). Results: In the total sample and three BMI categories, acrophase was the only circadian parameter that reached means established in healthy adults. In the total sample, phase-delayed acrophase was associated with higher depression (r = 0. 180, p = 0. 025) and lower morning energy (r = -0. 194, p = 0. 016) and trended for higher fatigue (r = 0. 153, p = 0. 057). Lower morning energy was also associated with a lower circadian quotient (r = 0. 158, p = 0. 05). As BMI increased, weaker circadian parameters were recorded consistently. When compared with women in normal BMI categories, obese women's amplitude and 24-h autocorrelation coefficient were significantly weaker (p = 0. 011-0. 015). In obese women, phase-delayed acrophase was correlated with higher fatigue and anxiety and with lower morning energy and physical functioning. Discussion/conclusions: Amplitude and 24-h autocorrelation parameters were significantly weaker, and phase-delayed acrophase was linked to several more intense symptoms and lower physical functioning in obese women. Implications for cancer survivors: Clinicians need to target high-risk women with phase-delayed rhythms, higher symptoms, and lower physical functioning for intervention.

Original languageEnglish (US)
Pages (from-to)305-314
Number of pages10
JournalJournal of Cancer Survivorship
Volume6
Issue number3
DOIs
StatePublished - Jul 1 2012

Fingerprint

Circadian Rhythm
Survivors
Body Mass Index
Breast Neoplasms
Fatigue
Anxiety
Depression
Wrist
Health Status
Disease-Free Survival
Sleep
Randomized Controlled Trials
Demography
Drug Therapy
Research
Neoplasms
Therapeutics

Keywords

  • Actigraph
  • Anxiety
  • Breast cancer
  • Circadian activity rhythm
  • Depression
  • Fatigue
  • Obesity
  • Physical functioning
  • Sleep

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)

Cite this

Circadian rhythms, symptoms, physical functioning, and body mass index in breast cancer survivors. / Berger, Ann Malone; Hertzog, Melody A; Geary, Carol R.; Fischer, Patricia; Farr, Lynne.

In: Journal of Cancer Survivorship, Vol. 6, No. 3, 01.07.2012, p. 305-314.

Research output: Contribution to journalArticle

Berger, Ann Malone ; Hertzog, Melody A ; Geary, Carol R. ; Fischer, Patricia ; Farr, Lynne. / Circadian rhythms, symptoms, physical functioning, and body mass index in breast cancer survivors. In: Journal of Cancer Survivorship. 2012 ; Vol. 6, No. 3. pp. 305-314.
@article{dfbf11bf1512413b965fd936655cfb41,
title = "Circadian rhythms, symptoms, physical functioning, and body mass index in breast cancer survivors",
abstract = "Introduction: Research has been limited in circadian activity rhythms and their relationship with health status in early-stage breast cancer survivors. Maintaining strong circadian parameters may reduce symptoms and improve physical functioning and disease-free survival. Methods: This is a descriptive, correlational, secondary analysis of data from a randomized controlled trial collected 1 year after the first chemotherapy treatment; n = 156 cases with 7 days of wrist actigraph data of six circadian activity rhythm parameters; measures of function, fatigue, sleep, and anxiety/depression; and demographic/medical data including body mass index (BMI). Results: In the total sample and three BMI categories, acrophase was the only circadian parameter that reached means established in healthy adults. In the total sample, phase-delayed acrophase was associated with higher depression (r = 0. 180, p = 0. 025) and lower morning energy (r = -0. 194, p = 0. 016) and trended for higher fatigue (r = 0. 153, p = 0. 057). Lower morning energy was also associated with a lower circadian quotient (r = 0. 158, p = 0. 05). As BMI increased, weaker circadian parameters were recorded consistently. When compared with women in normal BMI categories, obese women's amplitude and 24-h autocorrelation coefficient were significantly weaker (p = 0. 011-0. 015). In obese women, phase-delayed acrophase was correlated with higher fatigue and anxiety and with lower morning energy and physical functioning. Discussion/conclusions: Amplitude and 24-h autocorrelation parameters were significantly weaker, and phase-delayed acrophase was linked to several more intense symptoms and lower physical functioning in obese women. Implications for cancer survivors: Clinicians need to target high-risk women with phase-delayed rhythms, higher symptoms, and lower physical functioning for intervention.",
keywords = "Actigraph, Anxiety, Breast cancer, Circadian activity rhythm, Depression, Fatigue, Obesity, Physical functioning, Sleep",
author = "Berger, {Ann Malone} and Hertzog, {Melody A} and Geary, {Carol R.} and Patricia Fischer and Lynne Farr",
year = "2012",
month = "7",
day = "1",
doi = "10.1007/s11764-012-0218-x",
language = "English (US)",
volume = "6",
pages = "305--314",
journal = "Journal of Cancer Survivorship",
issn = "1932-2259",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Circadian rhythms, symptoms, physical functioning, and body mass index in breast cancer survivors

AU - Berger, Ann Malone

AU - Hertzog, Melody A

AU - Geary, Carol R.

AU - Fischer, Patricia

AU - Farr, Lynne

PY - 2012/7/1

Y1 - 2012/7/1

N2 - Introduction: Research has been limited in circadian activity rhythms and their relationship with health status in early-stage breast cancer survivors. Maintaining strong circadian parameters may reduce symptoms and improve physical functioning and disease-free survival. Methods: This is a descriptive, correlational, secondary analysis of data from a randomized controlled trial collected 1 year after the first chemotherapy treatment; n = 156 cases with 7 days of wrist actigraph data of six circadian activity rhythm parameters; measures of function, fatigue, sleep, and anxiety/depression; and demographic/medical data including body mass index (BMI). Results: In the total sample and three BMI categories, acrophase was the only circadian parameter that reached means established in healthy adults. In the total sample, phase-delayed acrophase was associated with higher depression (r = 0. 180, p = 0. 025) and lower morning energy (r = -0. 194, p = 0. 016) and trended for higher fatigue (r = 0. 153, p = 0. 057). Lower morning energy was also associated with a lower circadian quotient (r = 0. 158, p = 0. 05). As BMI increased, weaker circadian parameters were recorded consistently. When compared with women in normal BMI categories, obese women's amplitude and 24-h autocorrelation coefficient were significantly weaker (p = 0. 011-0. 015). In obese women, phase-delayed acrophase was correlated with higher fatigue and anxiety and with lower morning energy and physical functioning. Discussion/conclusions: Amplitude and 24-h autocorrelation parameters were significantly weaker, and phase-delayed acrophase was linked to several more intense symptoms and lower physical functioning in obese women. Implications for cancer survivors: Clinicians need to target high-risk women with phase-delayed rhythms, higher symptoms, and lower physical functioning for intervention.

AB - Introduction: Research has been limited in circadian activity rhythms and their relationship with health status in early-stage breast cancer survivors. Maintaining strong circadian parameters may reduce symptoms and improve physical functioning and disease-free survival. Methods: This is a descriptive, correlational, secondary analysis of data from a randomized controlled trial collected 1 year after the first chemotherapy treatment; n = 156 cases with 7 days of wrist actigraph data of six circadian activity rhythm parameters; measures of function, fatigue, sleep, and anxiety/depression; and demographic/medical data including body mass index (BMI). Results: In the total sample and three BMI categories, acrophase was the only circadian parameter that reached means established in healthy adults. In the total sample, phase-delayed acrophase was associated with higher depression (r = 0. 180, p = 0. 025) and lower morning energy (r = -0. 194, p = 0. 016) and trended for higher fatigue (r = 0. 153, p = 0. 057). Lower morning energy was also associated with a lower circadian quotient (r = 0. 158, p = 0. 05). As BMI increased, weaker circadian parameters were recorded consistently. When compared with women in normal BMI categories, obese women's amplitude and 24-h autocorrelation coefficient were significantly weaker (p = 0. 011-0. 015). In obese women, phase-delayed acrophase was correlated with higher fatigue and anxiety and with lower morning energy and physical functioning. Discussion/conclusions: Amplitude and 24-h autocorrelation parameters were significantly weaker, and phase-delayed acrophase was linked to several more intense symptoms and lower physical functioning in obese women. Implications for cancer survivors: Clinicians need to target high-risk women with phase-delayed rhythms, higher symptoms, and lower physical functioning for intervention.

KW - Actigraph

KW - Anxiety

KW - Breast cancer

KW - Circadian activity rhythm

KW - Depression

KW - Fatigue

KW - Obesity

KW - Physical functioning

KW - Sleep

UR - http://www.scopus.com/inward/record.url?scp=84865988198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865988198&partnerID=8YFLogxK

U2 - 10.1007/s11764-012-0218-x

DO - 10.1007/s11764-012-0218-x

M3 - Article

VL - 6

SP - 305

EP - 314

JO - Journal of Cancer Survivorship

JF - Journal of Cancer Survivorship

SN - 1932-2259

IS - 3

ER -